English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
×
Site Menu
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
PRNewsWire - Health
Smartee Unveils 'Live Update' to Slash Treatment Planning Time from Days to Seconds
Smartee Unveils 'Live Update' to Slash Treatment Planning Time from Days to Seconds
Share this via
Full Coverage
ESTEVE to acquire medicine to treat medullary thyroid cancer
ESTEVE to acquire medicine to treat medullary thyroid cancer
Share this via
Full Coverage
ESTEVE acquiert un médicament pour traiter le cancer médullaire de la thyroïde
ESTEVE acquiert un médicament pour traiter le cancer médullaire de la thyroïde
Share this via
Full Coverage
ESTEVE erwirbt Arzneimittel zur Behandlung von medullärem Schilddrüsenkrebs
ESTEVE erwirbt Arzneimittel zur Behandlung von medullärem Schilddrüsenkrebs
Share this via
Full Coverage
First
Prev.
21
22
23
24
25
26
27
Next
Last
Trending
1.
Joann's closing
2.
Texas Tech basketball
3.
UNC basketball
4.
Monster Hunter Wilds
5.
Ketamine
6.
Macron
7.
UPMC Memorial shooting
8.
Eagles
9.
Hims stock
10.
Joel Embiid
Popular News
BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
3 weeks ago
23
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulat...
Share this via
The mortgage market hopes for rate cuts amid war moves
3 weeks ago
21
The mortgage market hopes for rate cuts amid war moves
Share this via
Ukraine returns bodies of 3 Russian soldiers repatriated as ...
3 weeks ago
19
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry...
Share this via
BrightGene presenteert positieve fase 2 gegevens voor de dua...
3 weeks ago
19
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbehe...
Share this via
BrightGene présente des données positives de phase 2 pour so...
3 weeks ago
18
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la ge...
Share this via
.png)
German (DE) 
English (US) 
Spanish (ES) 
French (FR) 
Hindi (IN) 
Italian (IT) 
Russian (RU) 
